Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln GLA Variant in Anderson-Fabry Disease.
Rocío BlancoYolanda Rico-RamírezÁlvaro Hermida-AmeijeirasIsraa Mahmoud Sanad AbdullahKolja LauJorge Alvarez-RubioElena FortunyAmparo Martínez-MonzonísAlbina NowakPeter NordbeckCarlos Veras-BurgosJaume Pons-LlinaresEmiliano RossiFiama Giuliana Caimi-MartinezTeresa Bosch-RoviraMarta Alamar-CerveraVirginia Ruiz-PizarroLaura Torres-JuanDamian Heine-SunerTomas Ripoll-VeraPublished in: International journal of molecular sciences (2024)
The p.Arg301Gln variant in the α -galactosidase A gene ( GLA ) has been poorly described in the literature. The few reports show controversial information, with both classical and nonclassical Anderson-Fabry Disease (AFD) presentation patterns. The aim of this study was to analyze the penetrance, clinical phenotype, and biochemical profile of an international cohort of patients carrying the p.Arg301Gln genetic variant in the GLA gene. This was an observational, international, and retrospective cohort case series study of patients carrying the p.Arg301Gln variant in the GLA gene associated with AFD disease. Forty-nine p.Arg301Gln GLA carriers, 41% male, were analyzed. The penetrance was 63% in the entire cohort and 1.5 times higher in men. The mean age of symptoms onset was 41 years; compared to women, men presented symptoms earlier and with a shorter delay to diagnosis. The typical clinical triad-cornea verticillate, neuropathic pain, and angiokeratomas-affected only 20% of the cohort, with no differences between genders. During follow-up, almost 20% of the patients presented some type of nonfatal cardiovascular and renal event (stroke, need for dialysis, heart failure, and arrhythmias requiring intracardiac devices), predominantly affecting men. Residual levels were the most common finding of α-GAL A enzyme activity, only a few women had a normal level; a small proportion of men had undetectable levels. The incidence of combined outcomes including all causes of death was 33%, and the cumulative incidence of all-cause mortality was 9% at the follow-up. Patients carrying the p.Arg301Gln GLA variant have a high penetrance, with predominantly cardiorenal involvement and clinical onset of the disease in middle age. Only a small proportion showed the classic clinical presentation of AFD. As in other X-linked diseases, males were more affected by severe cardiovascular and renal events. This genotype-phenotype correlation could be useful from a practical clinical point of view and for future decision making.
Keyphrases
- end stage renal disease
- heart failure
- chronic kidney disease
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- neuropathic pain
- genome wide
- copy number
- systematic review
- type diabetes
- prognostic factors
- polycystic ovary syndrome
- patient reported outcomes
- poor prognosis
- healthcare
- spinal cord
- dna methylation
- metabolic syndrome
- african american
- sleep quality
- replacement therapy
- hypertrophic cardiomyopathy
- pregnancy outcomes
- current status
- insulin resistance
- smoking cessation